Srividhya Swaminathan

Herston, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Journal: Clinical & translational immunology
Published: January 31, 2025

Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity.

Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity.

Journal: iScience
Published: August 07, 2023

Limited Recognition of Highly Conserved Regions of SARS-CoV-2.

Limited Recognition of Highly Conserved Regions of SARS-CoV-2.

Journal: Microbiology spectrum
Published: February 24, 2022

Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3.

Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3.

Journal: Nature communications
Published: January 25, 2022

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants.

Journal: PLoS pathogens
Published: December 17, 2021

Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.

Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.

Journal: Clinical & translational immunology
Published: July 06, 2021

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.

CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.

Journal: Immunity
Published: January 22, 2021

Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.

Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.

Journal: Clinical & translational immunology
Published: September 09, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026